Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408-Reference-Cited by-同舟云学术

Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408

Published:2014-11 Issue: Volume:743 Page:89-97
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Milne Brian^ORCID,Jhamandas Khem,Sutak Maaja,Grenier Patrick,Cahill Catherine M.

Funder

Canadian Institutes of Health Research

Canada Research Chairs

Publisher

Elsevier BV

Subject

Pharmacology

Reference27 articles.

1. Different mechanisms mediate development and expression of tolerance and dependence for peripheral μ-opioid antinociception in the rat;Aley;J. Neurosci.,1997

2. Antagonists of excitatory opioid receptor functions enhance morphine׳s analgesic potency and attenuate opioid tolerance/dependence liability;Crain;Pain,2000

3. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons thereby increasing its anti-nociceptive potency and attenuating tolerance/dependence during chronic cotreatment;Crain;Proc. Natl. Acad. Sci. USA,1995

4. A method for determining loss of pain sensation;D’Amour;J. Pharmacol. Exp. Ther.,1941

5. Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism;Dwyer;Int. J. Neuropsychophysiol.,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction;Pharmaceuticals;2022-02-10

2. Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex;Pharmacology Biochemistry and Behavior;2018-09

3. Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists;Behavioural Pharmacology;2018-04

4. Endogenous Opiates and Behavior: 2015;Peptides;2017-02

5. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors;Neuropharmacology;2015-12